Company Filing History:
Years Active: 2000
Title: **Jarkko Rughonen: Innovator in Siloxane-Based Elastomers**
Introduction
Jarkko Rughonen, a talented inventor based in Vanhalinna, Finland, is recognized for his significant contributions to materials science, particularly in the development of siloxane-based elastomers. His innovative approach has led to advancements in drug permeation control, a crucial area in pharmaceutical applications. With one patent to his name, Jarkko exemplifies the spirit of innovation and dedication in the field.
Latest Patents
Rughonen holds a patent titled “Elastomer, its preparation and use.” This invention revolves around a siloxane-based elastomer designed specifically for controlling the permeation of drugs. The elastomer incorporates unique 3,3,3-trifluoropropyl groups attached to the silicon atoms of the siloxane units. Furthermore, the patent details a method for preparing this elastomer, which can be achieved through two processes: either crosslinking a 3,3,3-trifluoropropyl-substituted vinyl-functional polysiloxane component with a silicon hydride-functional crosslinking agent in the presence of a catalyst or crosslinking a 3,3,3-trifluoropropyl-substituted polysiloxane component using a peroxide catalyst.
Career Highlights
Jarkko Rughonen works with Leiras Oy, a pharmaceutical company known for its dedication to innovation in medicine and drug delivery systems. Throughout his career, Rughonen has remained focused on enhancing material properties to create more effective solutions in the healthcare sector.
Collaborations
Collaboration is key in innovation, and Jarkko Rughonen has had the privilege of working alongside skilled professionals such as Tommi Markkula and Juha Ala-Sorvari. Their collective expertise has significantly contributed to the successful development and implementation of new technologies related to elastomeric materials.
Conclusion
In conclusion, Jarkko Rughonen stands out as an inventive force in the field of siloxane-based elastomers. His pioneering work not only contributes to advancements in drug delivery but also highlights the importance of collaboration within innovative environments. As he continues his work at Leiras Oy, the potential for further breakthroughs in materials science remains promising.